Portage Biotech
1 known investors
Portage Biotech is a clinical-stage immuno-oncology company developing first-in-class cancer therapies that target checkpoint resistance pathways. It manages a portfolio of five drug platforms with about 10 products in preclinical or clinical development, guiding immunotherapy assets from early research through human proof of concept.
Investors · 1
In the news
Frequently asked questions
- What does Portage Biotech do?
- Portage Biotech is a clinical-stage immuno-oncology company developing first-in-class cancer therapies that target checkpoint resistance pathways. It manages a portfolio of five drug platforms with about 10 products in preclinical or clinical development, guiding immunotherapy assets from early research through human proof of concept.
- Who are Portage Biotech's investors?
- Portage Biotech's investors include venBio Partners.